General Information of Drug Off-Target (DOT) (ID: OT8Q5UWS)

DOT Name Aquaporin-10 (AQP10)
Synonyms AQP-10; Aquaglyceroporin-10; Small intestine aquaporin
Gene Name AQP10
Related Disease
Chronic otitis media ( )
Breast cancer ( )
Breast carcinoma ( )
UniProt ID
AQP10_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
6F7H
Pfam ID
PF00230
Sequence
MVFTQAPAEIMGHLRIRSLLARQCLAEFLGVFVLMLLTQGAVAQAVTSGETKGNFFTMFL
AGSLAVTIAIYVGGNVSGAHLNPAFSLAMCIVGRLPWVKLPIYILVQLLSAFCASGATYV
LYHDALQNYTGGNLTVTGPKETASIFATYPAPYLSLNNGFLDQVLGTGMLIVGLLAILDR
RNKGVPAGLEPVVVGMLILALGLSMGANCGIPLNPARDLGPRLFTYVAGWGPEVFSAGNG
WWWVPVVAPLVGATVGTATYQLLVALHHPEGPEPAQDLVSAQHKASELETPASAQMLECK
L
Function
[Isoform 1]: Water channel that mediates water transport across cell membranes irrespective of the cytosolic pH. The channel is permeable to glycerol, especially when the cytosolic pH is acidified. Contributes to adipocyte water and glycerol permeability, and may thereby contribute to the utilization of glycerol derived from phospholipid degradation. May contribute to water transport in the intestine (Probable); [Isoform 2]: Water channel that mediates water transport across cell membranes, but that is not permeable to glycerol.
Tissue Specificity
Detected in epithelial cells on villi in the ileum, and also in stomach, jejunum, colon, rectum, white adipose tissue and placenta (at protein level) . Expressed in duodenum and jejunum. Highest expression in absorptive epithelial cells at the tips of villi in the jejunum . Detected in subcutaneous adipose tissue .
Reactome Pathway
Passive transport by Aquaporins (R-HSA-432047 )

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Chronic otitis media DIS3P3TG moderate Altered Expression [1]
Breast cancer DIS7DPX1 Limited Altered Expression [2]
Breast carcinoma DIS2UE88 Limited Altered Expression [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Regulation of Drug Effects of 2 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Aquaporin-10 (AQP10) increases the transport of Arsenic. [4]
Urea DMUK75B Approved Aquaporin-10 (AQP10) increases the uptake of Urea. [11]
------------------------------------------------------------------------------------
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Aquaporin-10 (AQP10). [3]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Aquaporin-10 (AQP10). [4]
Triclosan DMZUR4N Approved Triclosan decreases the expression of Aquaporin-10 (AQP10). [5]
Folic acid DMEMBJC Approved Folic acid decreases the expression of Aquaporin-10 (AQP10). [6]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Aquaporin-10 (AQP10). [8]
1,6-hexamethylene diisocyanate DMLB3RT Investigative 1,6-hexamethylene diisocyanate affects the expression of Aquaporin-10 (AQP10). [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Aquaporin-10 (AQP10). [7]
------------------------------------------------------------------------------------

References

1 Expression of aquaporins mRNAs in patients with otitis media.Acta Otolaryngol. 2018 Aug;138(8):701-707. doi: 10.1080/00016489.2018.1447685. Epub 2018 Apr 1.
2 Significant prognostic values of aquaporin mRNA expression in breast cancer.Cancer Manag Res. 2019 Feb 14;11:1503-1515. doi: 10.2147/CMAR.S193396. eCollection 2019.
3 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
4 In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
5 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
6 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
8 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
9 Gene profiles of THP-1 macrophages after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol In Vitro. 2009 Sep;23(6):1151-62. doi: 10.1016/j.tiv.2009.06.007. Epub 2009 Jun 13.
10 In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
11 Cloning and identification of a new member of water channel (AQP10) as an aquaglyceroporin. Biochim Biophys Acta. 2002 Jul 19;1576(3):335-40. doi: 10.1016/s0167-4781(02)00393-7.